Literature DB >> 9342360

Interaction of pigeon cytochrome c-(43-58) peptide analogs with either T cell antigen receptor or I-Ab molecule.

Y Itoh1, K Kajino, K Ogasawara, A Takahashi, K Namba, I Negishi, N Matsuki, K Iwabuchi, M Kakinuma, R A Good, K Onoé.   

Abstract

We determined that a pigeon cytochrome c-derived peptide, p43-58, possesses two anchor residues, 46 and 54, for binding with the I-Ab molecule that are compatible to the position 1 (P1) and position 9 (P9) of the core region in the major histocompatibility complex (MHC) class II binding peptides, respectively. In the present study to analyze each binding site between P1 and P9 of p43-58 to either I-Ab or T cell antigen receptor (TCR), we investigated T cell responses to a series of peptides (P2K, P3K, P4K, P5K, P6K, P7K, and P8E) that sequentially substituted charged amino acid residues for the residues at P2 to P8 of p43-58. T cells from C57BL/10 (I-Ab) mice immunized with P4K or P6K did not mount appreciable proliferative responses to the immunogens, but those primed with other peptides (P2K, P3K, P5K, P7K, and P8E) showed substantial responses in an immunogen-specific manner. It was demonstrated by binding studies that P1 and P9 functioned as main anchors and P4 and P6 functioned as secondary anchors to I-Ab. Analyses of Vbeta usage of T cell lines specific for these analogs suggested that P8 interacts with the complementarity-determining region 1 (CDR1)/CDR2 of the TCR beta chain. Furthermore, sequencing of the TCR on T cell hybridomas specific for these analogs indicated that P5 interacts with the CDR3 of the TCR beta chain. The present findings are consistent with the three-dimensional structure of the trimolecular complex that has been reported for TCR/peptide/MHC class I molecules.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9342360      PMCID: PMC23698          DOI: 10.1073/pnas.94.22.12047

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex.

Authors:  R H Schwartz
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

2.  Failure to find holes in the T-cell repertoire.

Authors:  K Ogasawara; W L Maloy; R H Schwartz
Journal:  Nature       Date:  1987 Jan 29-Feb 4       Impact factor: 49.962

3.  Structures of an MHC class II molecule with covalently bound single peptides.

Authors:  D H Fremont; W A Hendrickson; P Marrack; J Kappler
Journal:  Science       Date:  1996-05-17       Impact factor: 47.728

4.  Determination of the allele-specific antigen-binding site on I-Ak and I-Ab molecules.

Authors:  Y Itoh; K Kajino; K Ogasawara; M Katoh; K Namba; K Takami; K Iwabuchi; N S Braunstein; K Onoé
Journal:  Eur J Immunol       Date:  1996-06       Impact factor: 5.532

5.  An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex.

Authors:  K C Garcia; M Degano; R L Stanfield; A Brunmark; M R Jackson; P A Peterson; L Teyton; I A Wilson
Journal:  Science       Date:  1996-10-11       Impact factor: 47.728

6.  Structure of the complex between human T-cell receptor, viral peptide and HLA-A2.

Authors:  D N Garboczi; P Ghosh; U Utz; Q R Fan; W E Biddison; D C Wiley
Journal:  Nature       Date:  1996-11-14       Impact factor: 49.962

7.  The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3.

Authors:  P Ghosh; M Amaya; E Mellins; D C Wiley
Journal:  Nature       Date:  1995-11-30       Impact factor: 49.962

8.  Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor.

Authors:  U D Staerz; H G Rammensee; J D Benedetto; M J Bevan
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

9.  The specificity and orientation of a TCR to its peptide-MHC class II ligands.

Authors:  D B Sant'Angelo; G Waterbury; P Preston-Hurlburt; S T Yoon; R Medzhitov; S C Hong; C A Janeway
Journal:  Immunity       Date:  1996-04       Impact factor: 31.745

10.  The antigen-specific, major histocompatibility complex-restricted receptor on T cells. VI. An antibody to a receptor allotype.

Authors:  K Haskins; C Hannum; J White; N Roehm; R Kubo; J Kappler; P Marrack
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

View more
  3 in total

1.  Simultaneous activation of T helper function can augment the potency of dendritic cell-based cancer immunotherapy.

Authors:  Koji Teramoto; Yasuhiko Ohshio; Takuya Fujita; Jun Hanaoka; Keiichi Kontani
Journal:  J Cancer Res Clin Oncol       Date:  2013-02-15       Impact factor: 4.553

2.  Naturally occurring altered peptide ligands control Salmonella-specific CD4+ T cell proliferation, IFN-gamma production, and protective potency.

Authors:  Tanner M Johanns; James M Ertelt; Joseph C Lai; Jared H Rowe; Ross A Avant; Sing Sing Way
Journal:  J Immunol       Date:  2009-12-21       Impact factor: 5.422

3.  Physiological induction of regulatory Qa-1-restricted CD8+ T cells triggered by endogenous CD4+ T cell responses.

Authors:  Aditi Varthaman; Marc Clement; Jamila Khallou-Laschet; Giulia Fornasa; Anh-Thu Gaston; Michael Dussiot; Giuseppina Caligiuri; Harvey Cantor; Srinivas Kaveri; Antonino Nicoletti
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.